AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pharma company reports third quarter 2004 results.
2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) reported results for the fiscal quarter and 9 months ended September 30, 2004.
During the third quarter of 2004, Point achieved the following key milestones:
- Continued enrollment of the company's lead development compound, talabostat, in four phase 2 clinical trials. The four phase 2 trials involve subjects with: Advanced non-small cell lung cancer studying talabostat in combination with Taxotere; Advanced metastatic melanoma studying talabostat as a single agent; Advanced metastatic melanoma studying talabostat incombination with cisplatin; and Advanced chronic lymphocytic leukemia studying talabostat in combination with rituximab.
- Published in the August edition of Cancer Research a preclinical study confirming in vivo antitumor activity of talabostat.
- Announced two new preclinical programs in type 2 diabetes and vaccine adjuvants at the company's Annual Meeting of Stockholders.
- Presented the company's type 2 diabetes program at the Punk Ziegal Diabetes Symposium.
"We continue to enroll subjects in our four phase 2 clinical studies of talabostat and expect to report interim go/no-go results on at least one study in the fourth quarter of 2004. We were also pleased to announce two new preclinical programs in type 2 diabetes and vaccine adjuvants at our annual meeting of stockholders this August," said Donald R. Kiepert, Jr., president and chief executive officer of Point. "These new programs are a direct result of the knowledge and expertise that we have gained over the years in our dipeptidyl peptidase (DPP) inhibitor technology."
- Orthodontics company announces net loss per share of $0.27.
- Newspaper article from: Medical Devices & Surgical Technology Week March 23, 2003 700+ words
...profitability." The net loss for the fourth quarter of 2002, determined...This compares to a net loss for the fourth quarter of 2001 of $20.7 million...of $2.57. The GAAP net loss for the fourth quarter and full year of 2002...
- XL Capital Ltd Reports Fourth Quarter 2005 Net Loss of $821.9 Million, or a Net...
- Press release article from: PR Newswire February 8, 2006 700+ words
...also included a net loss of $808.9 million...Winterthur Decision. Net loss for the twelve months...2004 included a net loss of $558.2 million...third and fourth quarter natural catastrophes...third and fourth quarters events had on our...
- InforMax Announces Second Quarter Revenue and Net Loss Per Share Results.
- Press release article from: Business Wire August 1, 2001 700+ words
...Company also reported a net loss per share for the second quarter, excluding certain...Company had a second quarter net loss per share of $(0...year. The Company's net loss per share in the second quarter ended June 30, 2001...
- Burlington Coat Factory Reports First Quarter Sales and Net Loss.
- Press release article from: Business Wire October 5, 2004 700+ words
...today reported its sales and net loss for the first quarter ended August 28, 2004...Comparative store sales for the quarter increased 2.9%. Total sales for the comparative quarter increased 9.8%. Net loss for the three months ended...
- Cyberonics Reports Record Q3 Results; Record Q3 Sales of $18.4 Million; 41%...
- Press release article from: PR Newswire February 6, 2002 700+ words
...the last two quarters to 41% in Q3...for the third quarter ended January...last year. Net loss for the third...Business Unit net loss for the quarter ended January...for the same quarter last year. Net loss for the nine...
- NetMed Announces Third Quarter Results; Net Loss of $315,000 Compared to...
- Press release article from: PR Newswire November 13, 1998 700+ words
...The Company incurred a net loss for the quarter of $315,000 compared...period last year. The net loss for the prior year quarter included the one time...period in 1997. The net loss for the third quarter was $.03 per share...
- Align Technology, Inc. Reports Record Revenues of $29.2 Million for the Second...
- Press release article from: PR Newswire July 24, 2003 700+ words
...86.0 percent. The net loss for the second quarter of 2003, as reported...This compares to a net loss for the first quarter of 2003 of $10.7 million...19 per share, and a net loss for the second quarter of 2002 of $20.3 million...
- Proxim Corporation Reports Fourth Quarter and Year-End 2003 Financial Results;...
- Press release article from: PR Newswire January 27, 2004 700+ words
...GAAP, or pro-forma, net loss in the fourth quarter of 2003 was $(2...expenses. The pro-forma net loss in the fourth quarter of 2002 was $(1...recorded in the fourth quarter of 2002. The GAAP net loss attributable to common...
- GIGAMEDIA REPORTS NET LOSS OF NT$481.4 MLN FOR FY 2003.
- News wire article from: Asia Africa Intelligence Wire April 14, 2004 700+ words
...8 million in the third quarter of 2003. Net loss excludes minority interests...recorded during the fourth quarter of 2003. Net loss increased from NT$23...incurred during the fourth quarter. Net loss for the year declined by...
- New Focus Announces First Quarter 2003 Financial Results; Company Reports...
- Press release article from: Business Wire April 23, 2003 700+ words
...shares outstanding. The first quarter 2003 net loss included minimal restructuring...the computation of the first quarter's net loss per share reflects the company...shares outstanding. The fourth quarter net loss included minimal restructuring...
Source: HighBeam Research, Pharma company reports third quarter 2004 results.